/Novel Hyaluronidase Variants With Improved Stability And Pharmaceutical Composition Comprising The Same
Abstract
Disclosed are novel PH20 variants or fragments thereof with improved thermal stability and enzymatic activity of human hyaluronidase, which is an enzyme that hydrolyzes hyaluronic acid, and more particularly novel PH20 variants or fragments thereof including one or more amino acid residue substitutions in the variant having the amino acid sequence of SEQ ID NO: 3, wherein one or more amino acid residues at the N-terminus and/or the C-terminus are optionally further deleted.
Full Text
What is claimed is:
Disclosed are novel PH20 variants or fragments thereof with improved thermal stability and enzymatic activity of human hyaluronidase, which is an enzyme that hydrolyzes hyaluronic acid, and more particularly novel PH20 variants or fragments thereof including one or more amino acid residue substitutions in the variant having the amino acid sequence of SEQ ID NO: 3, wherein one or more amino acid residues at the N-terminus and/or the C-terminus are optionally further deleted.
Timeline
Filed
03/23/2026Published
07/09/2026Granted
Not AvailableIPC Codes(3)
C12N 9/26:acting on alpha-1, 4-glucosidic bonds, e.g. hyaluronidase, invertase, amylase
A61K 45/06:Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
C12N 15/63:Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression